Boston Scientific (NYSE:BSX) has completed the acquisition of Nalu Medical, expanding its presence in chronic pain treatment. The company has announced a pending US$14.5b deal for Penumbra, which ...

Jan 15 (Reuters) - Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 ...

Boston Scientific Corporation (NYSE:BSX) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds.

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and ...

Though Boston Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Affected AXIOS systems should not be used, agency says ...